STAA - STAAR Surgical Company
| Previous Close | 28.68 |
| Open | 28.93 |
| Bid | 28.52 x 800 |
| Ask | 28.55 x 1000 |
| Day's Range | 28.52 - 29.50 |
| 52 Week Range | 21.70 - 51.30 |
| Volume | 385,990 |
| Avg. Volume | 334,485 |
| Market Cap | 1.276B |
| Beta (3Y Monthly) | 2.52 |
| PE Ratio (TTM) | 179.06 |
| EPS (TTM) | 0.16 |
| Earnings Date | Oct 30, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 48.00 |
- Business Wire
STAAR Surgical Celebrates Visual Freedom with Jorgensen Family
STAAR Surgical Company (STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that Dr. Jorn S. Jorgensen successfully implanted the Company’s EVO Visian ICL in his son, Jannik Jorgensen, during a live-streamed event which also celebrated the opening of EuroEyes’ newest clinic. Dr. Jorgensen is the founder, chairman, executive director and CEO of the EuroEyes clinic group, with clinics across Germany, Denmark and China.
- Business Wire
STAAR Surgical to Report Third Quarter Results on October 30, 2019
STAAR Surgical Company (STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the third quarter ended September 27, 2019 on Wednesday, October 30, 2019 after the market close. STAAR will host a conference call and webcast on Wednesday, October 30 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and operational progress. To access the conference call (Conference ID 7170127), please dial 855-765-5684 for domestic participants and 262-912-6252 for international participants.
- Simply Wall St.
STAAR Surgical Company (NASDAQ:STAA) Has Attractive Fundamentals
Attractive stocks have exceptional fundamentals. In the case of STAAR Surgical Company (NASDAQ:STAA), there's is a...
- Simply Wall St.
Should STAAR Surgical Company’s (NASDAQ:STAA) Weak Investment Returns Worry You?
Today we'll look at STAAR Surgical Company (NASDAQ:STAA) and reflect on its potential as an investment. To be precise...
- Business Wire
STAAR Surgical Announces EVO ICL Clinical Program for Its 16th Annual Surgical Experts Summit in Paris, France From September 11 – 13, 2019
STAAR Surgical Company , a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing the EVO ICL Clinical Program which will be presented by Ophthalmic Surgeons to Ophthalmic Surgeons at its invitation only Surgical Experts Summit.
- Business Wire
STAAR Surgical Announces Strategic Alliance Agreement with Asian Eye Institute
STAAR Surgical Company (STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it has entered a strategic alliance with Asian Eye Institute, an eye care group with nine locations in the Philippines. “‘Amazing’, ‘Wow’, ‘It’s so clear’, and ‘I am so happy’ are the words I often hear after performing the Visian® EVO ICL procedure and I am confident and proud to partner with STAAR in offering the EVO family of lenses to my patients,” said Dr. Robert “Bobby” Edward Ang, M.D., senior consultant and Head of Cornea and Refractive Surgery Services at Asian Eye Institute.
- Thomson Reuters StreetEvents
Edited Transcript of STAA earnings conference call or presentation 31-Jul-19 8:30pm GMT
Q2 2019 STAAR Surgical Co Earnings Call
- Simply Wall St.
Should You Be Adding STAAR Surgical (NASDAQ:STAA) To Your Watchlist Today?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
- Motley Fool
Why STAAR Surgical Stock Is Skyrocketing Today
Great second-quarter earnings results sent the implantable contact lens maker's stock into orbit.
Motley FoolStaar Surgical Co (STAA) Q2 2019 Earnings Call Transcript
STAA earnings call for the period ending June 30, 2019.
- Zacks
Staar Surgical (STAA) Beats Q2 Earnings Estimates
Staar Surgical (STAA) delivered earnings and revenue surprises of 40.00% and -1.09%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Is STAAR Surgical Company's (NASDAQ:STAA) CEO Salary Justified?
In 2015 Caren Mason was appointed CEO of STAAR Surgical Company (NASDAQ:STAA). First, this article will compare CEO...
- Zacks
Staar Surgical (STAA) Reports Next Week: Wall Street Expects Earnings Growth
Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Is There An Opportunity With STAAR Surgical Company's (NASDAQ:STAA) 48% Undervaluation?
How far off is STAAR Surgical Company (NASDAQ:STAA) from its intrinsic value? Using the most recent financial data...
- ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STAAR Surgical Company - STAA
NEW YORK, NY / ACCESSWIRE / June 27, 2019 / Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical Company ("STAAR" or the "Company") (STAA). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. The investigation concerns whether STAAR and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
- Simply Wall St.
How Much Are STAAR Surgical Company (NASDAQ:STAA) Insiders Taking Off The Table?
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
